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Xenograft models are transforming our understanding of the output capabilities of primitive
human hematopoietic cells in vivo. However, many variables that affect posttransplantation
reconstitution dynamics remain poorly understood. Here, we show that an equivalent level
of human chimerism can be regenerated from human CD34+ cord blood cells transplanted
intravenously either with or without additional radiation-inactivated cells into 2- to 6-
month-old NOD-Rag1–/–-IL2Rgc–/– (NRG) mice given a more radioprotective conditioning
regimen than is possible in conventionally used, repair-deficient NOD-Prkdcscid/scid-IL2Rgc–/–
(NSG) hosts. Comparison of sublethally irradiated and non-irradiated NRG mice and
W41/W41 derivatives showed superior chimerism in theW41-deficient recipients, with some dif-
ferential effects on different lineage outputs. Consistently superior outputs were observed in
female recipients regardless of their genotype, age, or pretransplantation conditioning,
with greater differences apparent later after transplantation. These results define key
parameters for optimizing the sensitivity and minimizing the intraexperimental variability
of human hematopoietic xenografts generated in increasingly supportive immunodeficient
host mice. Copyright  2017 ISEH - International Society for Experimental Hematology.
Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
The discovery more than two decades ago that primitive
normal human hematopoietic cells can engraft and regenerate
hematopoiesis in CB17-scidmice proved to be a turning point
in the analysis of the earliest stages of human hematopoiesis
[1]. Subsequently, both empirically characterized and directly
introduced genetic modifications have produced dramatic
improvements in the diversity, level, and duration of human
hematopoietic cell chimerism that can be obtained in xeno-
grafted mouse models [2–4]. These improvements have led
to the identificationof subsets of humanCD34þ cells that reca-
pitulate the concept, now well advanced in the mouse system,
of multiple biologically distinct hematopoietic cell popula-
tions that produce different types of mature progeny over
time in transplanted recipients [5–8].
Early studies of nongenetic variables that affect chime-
rism levels attained in nonobese diabetic–severe combined
immunodeficient (NOD.CB17-Prkdcscid/J, NS) mice
included evidence of strong effects of the age of the mouse
transplanted [9], whether other cells were coinjected [10],
and the conditioning regimen used [11]. Most hematopoiet-
ic xenotransplantation studies now make use of NS mice
into which a null mutation of the gamma chain of the inter-
leukin 2 (IL2) receptor has been introduced (referred to as
NOD-Prkdcscid/scid-IL2Rgc–/– [NSG] mice). This modifica-
tion has the advantage of eliminating the generation of the
fatal thymic lymphomas that appear universally in NS mice
at between 3 and 6 months of age. NSG mice thus have a
normal lifespan and the dynamics of transplanted human
hematopoietic cells can be followed reproducibly for up
to a year. NSG mice also lack natural killer (NK) cells, in
contrast to NS mice, in which the levels of NK cells pro-
duced are still sufficient to suppress selectively the ability
of most CD34þCD38þ human hematopoietic cells to
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engraft the bone marrow (BM) and thus fail to display their
innate short-term repopulating activity [6,12]. Evidence
that the sex of the recipient can affect the level of chime-
rism obtained from either syngeneic (mouse) [13,14] or
xenogeneic (human) transplantations [15] has also been
reported.
More recently, NSG mice with various mutant c-kit al-
leles have been created and shown to be even more permis-
sive than NSG mice in terms of their support of human
hematopoietic cells obtained from transplantations of hu-
man cord blood (CB) cells [16–18]. Of particular interest
are c-kit-deficient NSG mice expressing a homozygous
W41 allele because these remain fertile. In C57BL/6(B6)-
W41/W41 mice, maintenance of the hematopoietic stem
cell (HSC) and downstream erythroid progenitor compart-
ments is sufficiently compromised to enable their repopula-
tion by transplanted B6-þ/þ HSCs without being subjected
to a lethally myeloablative treatment [19–21]. Key findings
from assessments of previously described ‘‘NSG-W41’’
mice transplanted with human hematopoietic cells include
an increase in the levels of human chimerism that they sup-
port compared with NSG mice, including the production of
human erythroid precursors and platelets detectable even in
the absence of any prior host conditioning [16–18].
However, for many future studies, particularly those with
the objective of assessing treatments of engrafted human ma-
lignant cells, the scid mutation (that encodes a defective
DNA repair protein [22]) is undesirable because it sensitizes
all of the host tissues markedly to many radiomimetic drugs
that would be likely candidates for inclusion in test treatment
protocols. Therefore, we initiated an examination of a radio-
resistant alternative to NSG-W41 mice and evaluated vari-
ables that might affect the level and duration of human
hematopoietic chimerism that would be supported.
Here, we report the relevance of a number of variables in
mice genetically identical to NSG mice but with a homozy-
gous Rag1null genotype and wild-type Prkdc genotype to
retain the same level of immunodeficiency but a normal
DNA repair capacity. We then introduced the W41/W41 ge-
notype into NOD-Rag1–/–-IL2Rgc–/– (NRG) mice to
generate a derivative strain. We refer to the latter as
‘‘SRG-W41’’ mice because they have been selected in the
F2 generation to be homozygous for the Sirpa [23],
Rag1-null, and IL2rgc-null alleles of the NRG mouse, as




Breeding colonies of NOD.Cg-Rag1tm1MomIl2rgtm1Wjl/SzJ (NRG)
and B6-KitW41/W41 (B6-W41/W41) mice originally obtained
from The Jackson Laboratory have been established for many
years in the Animal Resource Centre of the British Columbia Can-
cer Agency. Mice referred to here as ‘‘SRG-W41’’ were F2 mice
generated by intercrossing the F1 progeny of NRG with B6-W41/
W41 matings and then selecting the progeny that were homozygous
for the Sirpa allele, the null Rag1 and Il2rg alleles of the NRG
mouse, and the W41 mutant Kit allele of the B6-W41/W41 mouse
to obtain all of these alleles on an otherwise mixed segregating
NODxB6 (STOCK) background. Genotyping of ear notch samples
was performed by polymerase chain reaction (PCR) gel electro-
phoresis, except for determining the presence of two, one, or no
copies of the single nucleotide mutation that encodes the W41
allele, which were detected by Sanger sequencing of amplified
PCR products. All animal breeding and experiments were per-
formed according to regulations approved by the Animal Care
Committee of the University of British Columbia.
Human cells
CD34þ-enriched suspensions of human low-density CB cells
(O80% purities) were obtained using an EasySep kit (STEM-
CELL Technologies, Vancouver, Canada) from cryopreserved
cells originally acquired and processed as described previously
[5]. Human BM cells were obtained as discarded anonymized
autologous transplantation harvests from deceased patients. All
cells were obtained and used according to procedures approved
by the University of British Columbia Research Ethics Board.
Transplantation
Cells were injected intravenously into 7- to 12- or 21- to 25-week-
old male and female mice that had either not been irradiated at all
or had been irradiated with 137Cs g-rays or 250 kvp X-rays, as
indicated. All acute exposures involved irradiating mice at a
dose rate of 100–150 cGy/minute (for both types of ionizing radi-
ation). All NRG mice used as transplantation recipients were irra-
diated with 900 cGy of 137Cs g-rays given over a 3 hour period
(5 cGy/min) to allow significant repair of DNA damage in nonhe-
matopoietic cell types that have such capacity (e.g., intestinal
epithelial cells [24]). In mice given transplantations accompanied
by coinjected accessory cells, the latter consisted of 106 irradiated
(15 Gy) human BM cells. Mice were maintained under specific
pathogen-free conditions using protocols approved by the Animal
Care Committee of the University of British Columbia.
Flow cytometry
Absolute numbers of human CD34þ cells were determined using
appropriate antibodies and AccuCheck counting beads (Life Tech-
nologies, Carlsbad, CA) as described previously [25]. Human
CD45þ, glycophorin A (GPA) erythroid, CD45þCD33/15þ
granulocyte-macrophage (GM), CD45þCD19þ B-cells, and
FSClowCD41þCD61þ platelets were also quantified using previ-
ously described antibodies and their absolute numbers determined
in recipient peripheral blood (PB) samples using AccuCheck
counting beads (Life Technologies) [5,25].
Statistical analysis
Data analysis and graph generation made use of R version 3.2.3
[26]. Data shown are geometric means 6 SEM, with reconstitu-
tion data log transformed to improve fit to assumptions of normal
distribution and equal variance. Kaplan–Meier curves were pro-
duced using the R ‘‘survival’’ package. Pairwise differences
were examined using the Student t test. Multiple group compari-
sons were examined using one-way ANOVA with post hoc Tu-
key’s honest significant difference analysis.
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Results
NRG mice can support similar levels of human
hematopoietic cell chimerism as NSG mice
Given the different radiation sensitivities of NRG and NSG
mice [27], we first undertook experiments to develop a con-
ditioning regimen for NRG mice that would exploit the
selectively enhanced repair capacity of many of their nonhe-
matopoietic tissues. As expected, acute exposure (150 cGy/
min) to increasing doses of X-rays showed 750 cGy caused
100% mortality within 3 weeks, whereas 600 cGy was the
maximum dose that allowed the full survival of all mice in
that test group. However, an estimated equivalent split
dose protocol (two acute exposures of 400 cGy separated
by a 6-hour interval) also allowed all six mice tested to sur-
vive (Fig. 1). Subsequent studies showed that a similar result
could be obtained with 900 cGy of 137Cs g-rays spread over
3 hours (5 cGy/minute). This latter protocol was then adop-
ted for all subsequent experiments.
We then compared human CD34þ CB transplantation
outcomes in young (8- to 12-week-old) NRG mice with
those obtained in sex- and age-matched groups of NSG
mice conditioned with a radiobiologically similar, single
acute exposure (w100 cGy/min) to 315 cGy of 137Cs
g-rays (i.e., a near maximum sublethal dose that allows
the full long-term survival of NSG mice [27]). The dy-
namics of human hematopoietic cell chimerism obtained
from 2  104 human CD34þ CB cells (6 coinjected 106
irradiated BM cells according to the experiment) in the
BM and PB of these recipients was then tracked for up to
30 weeks. The results showed that, for at least 10 weeks,
both strains thus conditioned supported similar outputs of
total human CD45þ, GM, B-lymphoid, and erythroid cells,
as well as platelets, with a slight but insignificant favoring
of the NSG host thereafter (Fig. 1B).
Differential effects of recipient sex, age, and use of
coinjected irradiated human BM cells on the levels of
human chimerism obtained in NRG mice
We next examined the role of the sex and age (up to
6 months) of the NRG host or a coinjected dose of 106 irra-
diated (1500 cGy) human BM cells on the ability of 2  104
purified human CD34þ CB cells to regenerate both rapid
and sustained multilineage grafts in sublethally irradiated
NRG mice. Consistent with earlier data [15], assessments
of the chimerism seen in both the BM (Fig. 2A) and the
PB (Fig. 2B) showed that female mice generally supported
a greater output of all human lineages regardless of their
age when transplanted or whether additional cells were in-
jected. However, this greater supportive activity of the fe-
male hosts appeared slightly more pronounced on the
production of human B-lymphoid cells than on the produc-
tion of GM cells and the negative effect of using male re-
cipients was more marked when these were older or were
coinjected with irradiated cells.
Both irradiated and untreated SRG-W41 hosts support
elevated human chimerism compared with NRG mice
We then compared the human multilineage hematopoietic
cell outputs obtained from 2–5  104 human CB CD34þ
cells transplanted into both sublethally irradiated or
untreated male and female SRG-W41 and NRG mice. Pre-
vious studies had shown 400 cGy of 137Cs g-rays (given at
a high dose rate) to be an optimal sublethal conditioning
regimen for preparing B6-W41/W41 mice as hosts of B6
cells [20]. However, NRG mice are considerably more
radiosensitive than B6 mice, with an acute dose of
600 cGy X-rays on NRG mice (Fig. 1) being approxi-
mately equal to the effect of an acute dose of 900 137Cs
g-rays (w800 cGy X-rays) on B6 mice. We thus esti-
mated (and subsequently found) that a single dose of
150 cGy of 137Cs g-rays given at the high dose rate would
be a conservatively sublethal conditioning dose for SRG-
W41 mice.
Analysis of sequentially harvested BM aspirate cells
from the four different groups of sublethally irradiated re-
cipients again showed generally higher levels of human
chimerism in female versus male mice of the same geno-
type, particularly at later time points after transplantation
(Fig. 3A and B). In the male hosts, the outputs of human
cells in the SRG-W41 mice were consistently enhanced
compared with the NRG mice. In the female hosts, the
levels obtained in the NRG mice were initially already
very high, except in the erythroid lineage, so, not surpris-
ingly, there was little evidence of increased chimerism in
the SRG-W41 hosts.
The BM content of human hematopoietic cells obtained
from the same CD34þ CB cells injected into male and fe-
male SRG-W41 and NRG mice that had received no prior
treatment are shown in Figure 3C and D. Readily detectable
multilineage human cell chimerism was evident in both the
non-irradiated male and female SRG-W41 mice for the
entire 30 weeks of follow-up. Unexpectedly, parallel ana-
lyses of the non-irradiated female NRG recipients also re-
vealed detectable, albeit much lower, levels of human
GM and B-lymphoid cells in the BM. Even in the non-
irradiated male NRG recipients, low and transient levels
of human B-lymphoid cells were seen during the first
20 weeks.
The results of concurrently assessed PB samples ob-
tained from the same irradiated and untreated mice tracked
in these experiments were similar to those obtained for the
BM. Absolute counts of circulating human hematopoietic
cells in both female genotypes were higher than in the cor-
responding males independent of their prior conditioning;
furthermore, the results obtained in the SRG-W41 mice
were consistently higher than in the matched groups of
NRG mice (Fig. 4). Importantly, these differences extended
to the output of human platelets, which was uniquely sus-
tained for 30 weeks in untreated as well as irradiated female
SRG-W41 hosts.
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Figure 1. Similar human cell reconstitution of NSG and NRG mice. (A) Cohorts of 7- to 12-week-old NRG mice were X-irradiated at a high dose rate with
315 cGy (4 mice), 500 cGy (4 mice), 600 cGy (6 mice), 750 cGy (7 mice), or with two doses of 400 cGy separated by 6 hours (6 mice) and their survival was
then tracked. (B) Kinetics of human CD45þ, GM, B-lymphoid, and erythroid cell reconstitution of the BM (left column) and of numbers of human CD45þ,
GM, and B-lymphoid cells and platelets per milliliter of PB (right column) of NSG (open symbols) and NRG (filled symbols) mice after their transplantation
with 2  104 human CD34þ CB cells plus 106 irradiated human BM cells. Data are pooled from three replicate experiments with a combined total of 11 mice
per group. Asterisks indicate statistical significance (*p # 0.05).
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Discussion
Much interest is now focused on defining the hematopoietic
potential and activity of different types of primitive human
hematopoietic cells, how these properties are intrinsically
regulated, how they are elicited, and how they might be
manipulated. This interest inevitably relies on combining
molecular and genetic analyses of different phenotypes
with robust readouts of the number and types of maturing
progeny that they can generate under defined in vitro and
in vivo conditions. The use of sublethally irradiated highly
immunodeficient mice as hosts of intravenously transplant-
able human hematopoietic cells has proven an important
platform for gaining insights into such issues and revealing
the complexity of this system [2,3]. Despite many ad-
vances, however, species differences between humans and
mice continue to pose challenges to optimizing the sensi-
tivity and specificity of current assays that rely on trans-
plantation readouts. For example, assessments of human
repopulating cell activity that rely on measurements of total
chimerism obtained in recipients of bulk transplantations
are often used to infer HSC frequencies in the cell suspen-
sion being evaluated. Such surrogate approaches are valu-
able because they circumvent the cost and challenges of
larger-scale limiting dilution transplantation assays. How-
ever, any alteration in the numbers or types of the cells pro-
duced, or their assessment under conditions in which inputs
Figure 2. Female NRG mice support higher human cell outputs than male hosts. Female (orange bars) and male (blue bars) mice were each transplanted with
2  104 human CD34þ CB cells and assessed for percentage of viable human cells in the BM 20 weeks later (A), and numbers per milliliter of PB 3 (left
column), 12 (middle column), and 20 (right column) weeks later (B). The X-axis labels indicate the recipient sex, recipient age at transplantation in weeks,
and whether irradiated human BM cells were coinjected with the CB cells. Letters above the bars indicate groups that are not significantly different from each
other. Total numbers of mice in each group (from two experiments) were as follows: female, 8-12 weeks and no accessory cells: 20 mice; female, 21-25 weeks
and no accessory cells: 18 mice; female, 8-12 weeks and accessory cells: 5 mice; male, 8-12 weeks and no accessory cells: 24 mice; male, 21-25 weeks and
no accessory cells: 20 mice; male, 8-12 weeks and accessory cells: 4 mice; male, 21-25 weeks and accessory cells: 4 mice.
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and outputs are nonlinear, can compromise interpretation of
the results and the validity of using this approach to infer
input frequency values. The recent and anticipated
continuing creation of increasingly permissive recipient
mice for such studies of normal and perturbed human xeno-
grafts underscores the continuing need to address these
issues.
The Sirpa polymorphism and scid and IL2rg mutations
of NSG mice contribute to enhancing their reconstitution
by transplantations of human hematopoietic cells by re-
straining multiple components of the host mouse immune
system. Substitution of an inactivating mutation of the
Rag1 or Rag2 gene for the scid mutation results in a recip-
ient that is immunologically similar, but less radiosensitive.
Replacement of the c-kit gene with a mutant (e.g., W41)
allele enables even higher levels of human chimerism to
be obtained by impairing the competitiveness of the primi-
tive hematopoietic cells of the recipient. This latter genetic
alteration also enhances the output of human erythroid pre-
cursors selectively due to the important role of KIT in sus-
taining erythropoiesis in both mice and humans [28,29].
The ability of an added KIT deficiency to improve the
Figure 3. Enhanced human cell chimerism in the BM of SRG-W41 versus NRG mice. Shown are the kinetics of human cell reconstitution of the BM of
irradiated female (A), irradiated male (B), non-irradiated female (C), and non-irradiated male (D) mice (all 7-12 weeks of age at the time of the transplan-
tation). Results in SRG-W41 hosts are shown by the red symbols and for the parental NRG hosts in black. Mice were transplanted with 2–5  104 human
CD34þ CB cells and the percentages of total human CD45þ, GM, B-lymphoid, and erythroid cells in the BM were assessed in serial aspirates obtained 3, 6,
10, 20, and 30 weeks later. Circles and triangles indicate female and male mice, respectively. Results are pooled from three experiments with a combined total
of six to 10 mice per group. Asterisks indicate statistical significance (*p # 0.05; **p # 0.01).
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chimerism obtained in NOD, BALB/c, and mixed NOD-B6
genotypes has been reported recently by several groups
[16–18]. Although a number of mutant c-kit alleles have
been shown to confer this effect, the W41 mutation has
the advantage of not compromising the fertility of the
host strain. Here, we extend the demonstration of its utility
when combined with a Rag1null instead of a scid genotype,
to enable less radiotoxic conditioning regimens to be used.
This model should thus offer advantages in future studies
designed to test the effects of cytotoxic therapies that might
not be tolerated in c-kit-deficient NSG mice.
A systematic examination of variables historically re-
ported to affect the level, durability, and lineage contribu-
tions to the human chimerism obtained in NS and NSG
mice showed that concerns with the use of O12-week-old
mice as recipients [9] and the need for coinjected human
‘‘carrier’’ cells for transplantations of small cell numbers
[10] no longer pertain with NRG mice. In contrast, we
found the previously reported superiority of female recipi-
ents [15] remains a critical influence in SRG-W41 and
NRG recipients, regardless of whether they are irradiated
before performing the transplantation, with the most
Figure 4. Enhanced human cell numbers in the PB of transplanted SRG-W41 versus NRG mice. Kinetics of human cell numbers in the PB of the irradiated
female (A), irradiated male (B), non-irradiated female (C), and non-irradiated male (D) mice described in Figure 3. Results in SRG-W41 mice are again
shown by the red symbols and for the NRG mice in black. Numbers of human CD45þ, GM, and B-lymphoid cells and platelets per milliliter of recipient
blood were determined 3, 6, 10, 20, and 30 weeks after transplantation. Circles and triangles indicate female and male mice, respectively. Asterisks indicate
statistical significance (*p # 0.05; **p # 0.01; ***p # 0.001).
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pronounced effects seen at later time points up to 30 weeks
after transplantation.
As predicted by previous studies with NSG-W41 mice
[16–18], we found that SRG-W41 mice support greater hu-
man chimerism than parental NRG mice, although this dif-
ference was masked in the irradiated female recipients
studied here by the high chimerism already achieved in
the NRG mice by the number of human CD34þ CB cells
injected. Of particular note was the marked effect obtained
in female NRG and SRG-W41 mice in enhancing the num-
ber of circulating human platelets. This finding, together
with the enhanced human erythropoiesis also seen, con-
firms the utility of immunodeficient mice with an additional
W41 mutant genotype for studies of manipulations that
cause or might correct the delayed platelet recovery charac-
teristic of many human transplantations. Importantly, all of
the experiments reported here made use of expanded F2
progeny generated from NRG  B6-W41 F1 mice selected
exclusively for homozygosity for the four allelic differences
between these two strains anticipated to be relevant to their
utility as improved hosts of human cells. The consistency of
the xenograft results obtained using them reinforces previ-
ous evidence that the Sirpa allele unique to NOD mice ac-
counts for most, if not all, of the permissivity that it
contributes [23,30]. Continued backcrossing to obtain
more broadly homogeneous genotypes on both NOD and
B6 backgrounds is ongoing and will eventually allow this
inference to be tested more rigorously.
The extent to which any of the observed recipient sex,
genotype, or conditioning regimen-associated differences
in chimerism are driven by effects on the initial level of re-
populating cell engraftment or stimulation obtained, as
opposed to subsequent downstream effects on their output
of differentiating cells, remains unresolved. The high fre-
quency of clones derived from injections of highly purified
human HSCs [8] argues in favor of the latter, at least for
cells with long-term in vivo repopulating activity. However,
this latter observation does not rule out a contribution from
an increased seeding efficiency or initial activation of hu-
man cells in an environment where their endogenous mouse
counterparts have a reduced responsiveness to the KIT
ligand.
In summary, we have analyzed multiple factors that affect
the level of repopulation of immunodeficient mice by intra-
venously transplanted human CD34þ CB cells. The results
demonstrate variable effects early after transplantation,
with maximal and readily detectable levels of human B-line-
age cells, GM cells, erythroid precursors, and circulating
platelets evident for at least 30 weeks in sublethally irradi-
ated female SRG-W41 mice. These findings should facilitate
future investigation of the mechanisms of this enhanced
chimerism in both irradiated and unconditioned recipients
and show the utility of these mice for improving human
cell and gene therapy and in studies of human leukemic
cell growth and treatment response.
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